Sort
4,870 grants matching “glp 1”
Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease
$115,125Rodolfo Galindo · University Of Miami School Of Medicine · R03 · FY2024 · DK
GLP1R neurons in the subfornical organ and integration of thirst and satiety cues
$115,019Rui Chang · Harvard Medical School · K01 · FY2017 · DK
CORE--MICROARRAY &ANALYSIS SHARED SERVICE
$114,467University Of Pittsburgh At Pittsburgh · P30 · FY2005 · CA
The effects of obesity and GLP-1R/GIPR agonists on early-onset breast cancer risk
$114,250Steven K. Libutti · Rutgers Biomedical And Health Sciences · P30 · FY2025 · CA
Rapid Sampling for Resistant S. Pneumonaie in Guatemala
$114,248Johns Hopkins University · K01 · FY2004 · TW
Rapid Sampling for Resistant S. Pneumonaie in Guatemala
$114,248Johns Hopkins University · K01 · FY2005 · TW
Rapid Sampling for Resistant S. Pneumonaie in Guatemala
$114,248Johns Hopkins University · K01 · FY2003 · TW
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
$114,070Chee W Chia · National Institute On Aging · ZIA · FY2016 · AG
Clinical Pharmacology Shared Resource
$114,049Gregory Allen Reed · University Of Kansas Medical Center · P30 · FY2017 · CA
Investigations of botanicals on food intake, satiety, weight loss, and oxidative
$113,925Stephen D Anton · University Of Florida · K23 · FY2009 · AT
Pharmacology and Pharmacometrics Core
$113,866Eric L Nuermberger · Johns Hopkins University · P30 · FY2024 · AI
CORE--BIOCOMPATIBILITY
$113,856University Of Missouri Kansas City · P01 · FY2004 · DE
CORE--BIOCOMPATIBILITY
$113,856University Of Missouri Kansas City · P01 · FY2005 · DE
CORE--BIOCOMPATIBILITY
$113,856University Of Missouri Kansas City · P01 · FY2001 · DE
CORE--BIOCOMPATIBILITY
$113,856University Of Missouri Kansas City · P01 · FY2002 · DE
CORE--BIOCOMPATIBILITY
$113,856University Of Missouri Kansas City · P01 · FY2003 · DE
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.
$112,264Melanie Schorr Haines · Massachusetts General Hospital · R03 · FY2022 · DK
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.
$112,264Melanie Schorr Haines · Massachusetts General Hospital · R03 · FY2023 · DK
Administrative Core
$111,899Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA
Prostatic Effects of Chronic Exposure to Bisphenol A in a Rat Model
$111,771Gail S Prins · University Of Illinois At Chicago · U01 · FY2011 · ES
Scientific Core
$111,689Tim Mosmann · University Of Rochester · U19 · FY2012 · AI
Novel Agonists and Inverse Agonists for B-Family GPCRs
$111,646Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2023 · GM
Analytical Pharmacology Core
$111,538Timothy W Synold · Beckman Research Institute/City Of Hope · P30 · FY2021 · CA
Analytical Pharmacology Core
$111,538Timothy W Synold · Beckman Research Institute/City Of Hope · P30 · FY2022 · CA
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
$111,375James Andrew Hardaway · University Of Alabama At Birmingham · R03 · FY2021 · DK